Idremcinal

伊屈西那

Report date: 2026/03/06 20:02:51
NME

Base Information

Drug NameIdremcinal
Drug Alias NameidremcinalumEM-574
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMotilin receptor agonists
TargetsMotilin receptor
Therapy Area/IndicationsGastritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsGastritis

Other Information

ATC CodeN/A
Related LinksKEGG